nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00394	0.00394	CcSEcCtD
Verteporfin—Cough—Progesterone—uterine cancer	0.00393	0.00393	CcSEcCtD
Verteporfin—Scotoma—Epirubicin—uterine cancer	0.00389	0.00389	CcSEcCtD
Verteporfin—Hypertension—Progesterone—uterine cancer	0.00388	0.00388	CcSEcCtD
Verteporfin—Chest pain—Progesterone—uterine cancer	0.00383	0.00383	CcSEcCtD
Verteporfin—Arthralgia—Progesterone—uterine cancer	0.00383	0.00383	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.0038	0.0038	CcSEcCtD
Verteporfin—Blister—Doxorubicin—uterine cancer	0.00379	0.00379	CcSEcCtD
Verteporfin—Discomfort—Progesterone—uterine cancer	0.00378	0.00378	CcSEcCtD
Verteporfin—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00378	0.00378	CcSEcCtD
Verteporfin—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00377	0.00377	CcSEcCtD
Verteporfin—Hyperaesthesia—Epirubicin—uterine cancer	0.00376	0.00376	CcSEcCtD
Verteporfin—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00368	0.00368	CcSEcCtD
Verteporfin—Oedema—Progesterone—uterine cancer	0.00367	0.00367	CcSEcCtD
Verteporfin—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00366	0.00366	CcSEcCtD
Verteporfin—Albuminuria—Doxorubicin—uterine cancer	0.00366	0.00366	CcSEcCtD
Verteporfin—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00366	0.00366	CcSEcCtD
Verteporfin—Pharyngitis—Dactinomycin—uterine cancer	0.00363	0.00363	CcSEcCtD
Verteporfin—Injection site pain—Epirubicin—uterine cancer	0.00361	0.00361	CcSEcCtD
Verteporfin—Shock—Progesterone—uterine cancer	0.00361	0.00361	CcSEcCtD
Verteporfin—Nervous system disorder—Progesterone—uterine cancer	0.0036	0.0036	CcSEcCtD
Verteporfin—Scotoma—Doxorubicin—uterine cancer	0.0036	0.0036	CcSEcCtD
Verteporfin—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00358	0.00358	CcSEcCtD
Verteporfin—Skin disorder—Progesterone—uterine cancer	0.00357	0.00357	CcSEcCtD
Verteporfin—Hyperhidrosis—Progesterone—uterine cancer	0.00355	0.00355	CcSEcCtD
Verteporfin—Hyperaesthesia—Doxorubicin—uterine cancer	0.00348	0.00348	CcSEcCtD
Verteporfin—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00347	0.00347	CcSEcCtD
Verteporfin—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00347	0.00347	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00345	0.00345	CcSEcCtD
Verteporfin—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00343	0.00343	CcSEcCtD
Verteporfin—Flushing—Dactinomycin—uterine cancer	0.00339	0.00339	CcSEcCtD
Verteporfin—Extravasation—Epirubicin—uterine cancer	0.00338	0.00338	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00334	0.00334	CcSEcCtD
Verteporfin—Injection site pain—Doxorubicin—uterine cancer	0.00334	0.00334	CcSEcCtD
Verteporfin—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00333	0.00333	CcSEcCtD
Verteporfin—Dyspnoea—Progesterone—uterine cancer	0.00327	0.00327	CcSEcCtD
Verteporfin—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00327	0.00327	CcSEcCtD
Verteporfin—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00326	0.00326	CcSEcCtD
Verteporfin—Arthropathy—Epirubicin—uterine cancer	0.00324	0.00324	CcSEcCtD
Verteporfin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00323	0.00323	CcSEcCtD
Verteporfin—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00322	0.00322	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Progesterone—uterine cancer	0.00317	0.00317	CcSEcCtD
Verteporfin—Constipation—Progesterone—uterine cancer	0.00314	0.00314	CcSEcCtD
Verteporfin—Pain—Progesterone—uterine cancer	0.00314	0.00314	CcSEcCtD
Verteporfin—Extravasation—Doxorubicin—uterine cancer	0.00313	0.00313	CcSEcCtD
Verteporfin—Creatinine increased—Epirubicin—uterine cancer	0.0031	0.0031	CcSEcCtD
Verteporfin—Inflammation—Epirubicin—uterine cancer	0.00304	0.00304	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00303	0.00303	CcSEcCtD
Verteporfin—Feeling abnormal—Progesterone—uterine cancer	0.00303	0.00303	CcSEcCtD
Verteporfin—Arthropathy—Doxorubicin—uterine cancer	0.003	0.003	CcSEcCtD
Verteporfin—Musculoskeletal pain—Epirubicin—uterine cancer	0.00299	0.00299	CcSEcCtD
Verteporfin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00297	0.00297	CcSEcCtD
Verteporfin—Pneumonia—Etoposide—uterine cancer	0.00296	0.00296	CcSEcCtD
Verteporfin—Ill-defined disorder—Dactinomycin—uterine cancer	0.00295	0.00295	CcSEcCtD
Verteporfin—Anaemia—Dactinomycin—uterine cancer	0.00294	0.00294	CcSEcCtD
Verteporfin—Injection site reaction—Epirubicin—uterine cancer	0.00293	0.00293	CcSEcCtD
Verteporfin—Urticaria—Progesterone—uterine cancer	0.00292	0.00292	CcSEcCtD
Verteporfin—Acute coronary syndrome—Etoposide—uterine cancer	0.0029	0.0029	CcSEcCtD
Verteporfin—Body temperature increased—Progesterone—uterine cancer	0.0029	0.0029	CcSEcCtD
Verteporfin—Myocardial infarction—Etoposide—uterine cancer	0.00289	0.00289	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00287	0.00287	CcSEcCtD
Verteporfin—Creatinine increased—Doxorubicin—uterine cancer	0.00287	0.00287	CcSEcCtD
Verteporfin—Malaise—Dactinomycin—uterine cancer	0.00287	0.00287	CcSEcCtD
Verteporfin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.00284	CcSEcCtD
Verteporfin—Inflammation—Doxorubicin—uterine cancer	0.00281	0.00281	CcSEcCtD
Verteporfin—Musculoskeletal pain—Doxorubicin—uterine cancer	0.00276	0.00276	CcSEcCtD
Verteporfin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00274	0.00274	CcSEcCtD
Verteporfin—Dry eye—Epirubicin—uterine cancer	0.00273	0.00273	CcSEcCtD
Verteporfin—Injection site reaction—Doxorubicin—uterine cancer	0.00271	0.00271	CcSEcCtD
Verteporfin—Hypersensitivity—Progesterone—uterine cancer	0.0027	0.0027	CcSEcCtD
Verteporfin—Discomfort—Dactinomycin—uterine cancer	0.00267	0.00267	CcSEcCtD
Verteporfin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00264	0.00264	CcSEcCtD
Verteporfin—Asthenia—Progesterone—uterine cancer	0.00263	0.00263	CcSEcCtD
Verteporfin—Hypoaesthesia—Etoposide—uterine cancer	0.00263	0.00263	CcSEcCtD
Verteporfin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00263	0.00263	CcSEcCtD
Verteporfin—Pruritus—Progesterone—uterine cancer	0.0026	0.0026	CcSEcCtD
Verteporfin—Oedema—Dactinomycin—uterine cancer	0.00259	0.00259	CcSEcCtD
Verteporfin—Dry eye—Doxorubicin—uterine cancer	0.00252	0.00252	CcSEcCtD
Verteporfin—Eye disorder—Etoposide—uterine cancer	0.00247	0.00247	CcSEcCtD
Verteporfin—Flushing—Etoposide—uterine cancer	0.00245	0.00245	CcSEcCtD
Verteporfin—Cardiac disorder—Etoposide—uterine cancer	0.00245	0.00245	CcSEcCtD
Verteporfin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00245	0.00245	CcSEcCtD
Verteporfin—Photosensitivity—Epirubicin—uterine cancer	0.00244	0.00244	CcSEcCtD
Verteporfin—Dizziness—Progesterone—uterine cancer	0.00243	0.00243	CcSEcCtD
Verteporfin—Angiopathy—Etoposide—uterine cancer	0.0024	0.0024	CcSEcCtD
Verteporfin—Immune system disorder—Etoposide—uterine cancer	0.00239	0.00239	CcSEcCtD
Verteporfin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00239	0.00239	CcSEcCtD
Verteporfin—Eczema—Epirubicin—uterine cancer	0.00238	0.00238	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00236	0.00236	CcSEcCtD
Verteporfin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.00235	CcSEcCtD
Verteporfin—Rash—Progesterone—uterine cancer	0.00231	0.00231	CcSEcCtD
Verteporfin—Dermatitis—Progesterone—uterine cancer	0.00231	0.00231	CcSEcCtD
Verteporfin—Headache—Progesterone—uterine cancer	0.0023	0.0023	CcSEcCtD
Verteporfin—Photosensitivity—Doxorubicin—uterine cancer	0.00226	0.00226	CcSEcCtD
Verteporfin—Dermatitis bullous—Epirubicin—uterine cancer	0.00224	0.00224	CcSEcCtD
Verteporfin—Back pain—Etoposide—uterine cancer	0.00223	0.00223	CcSEcCtD
Verteporfin—Pain—Dactinomycin—uterine cancer	0.00222	0.00222	CcSEcCtD
Verteporfin—Eczema—Doxorubicin—uterine cancer	0.00221	0.00221	CcSEcCtD
Verteporfin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0022	0.0022	CcSEcCtD
Verteporfin—Nausea—Progesterone—uterine cancer	0.00218	0.00218	CcSEcCtD
Verteporfin—Osteoarthritis—Epirubicin—uterine cancer	0.00214	0.00214	CcSEcCtD
Verteporfin—Diplopia—Epirubicin—uterine cancer	0.00214	0.00214	CcSEcCtD
Verteporfin—Feeling abnormal—Dactinomycin—uterine cancer	0.00214	0.00214	CcSEcCtD
Verteporfin—Ill-defined disorder—Etoposide—uterine cancer	0.00214	0.00214	CcSEcCtD
Verteporfin—Anaemia—Etoposide—uterine cancer	0.00213	0.00213	CcSEcCtD
Verteporfin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.0021	CcSEcCtD
Verteporfin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.0021	CcSEcCtD
Verteporfin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00208	0.00208	CcSEcCtD
Verteporfin—Malaise—Etoposide—uterine cancer	0.00208	0.00208	CcSEcCtD
Verteporfin—Dermatitis bullous—Doxorubicin—uterine cancer	0.00207	0.00207	CcSEcCtD
Verteporfin—Vertigo—Etoposide—uterine cancer	0.00207	0.00207	CcSEcCtD
Verteporfin—Body temperature increased—Dactinomycin—uterine cancer	0.00205	0.00205	CcSEcCtD
Verteporfin—Loss of consciousness—Etoposide—uterine cancer	0.00202	0.00202	CcSEcCtD
Verteporfin—Cough—Etoposide—uterine cancer	0.00201	0.00201	CcSEcCtD
Verteporfin—Blood creatinine increased—Epirubicin—uterine cancer	0.00201	0.00201	CcSEcCtD
Verteporfin—Hypertension—Etoposide—uterine cancer	0.00199	0.00199	CcSEcCtD
Verteporfin—Osteoarthritis—Doxorubicin—uterine cancer	0.00198	0.00198	CcSEcCtD
Verteporfin—Diplopia—Doxorubicin—uterine cancer	0.00198	0.00198	CcSEcCtD
Verteporfin—Liver function test abnormal—Epirubicin—uterine cancer	0.00198	0.00198	CcSEcCtD
Verteporfin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.00198	CcSEcCtD
Verteporfin—Chest pain—Etoposide—uterine cancer	0.00196	0.00196	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00195	0.00195	CcSEcCtD
Verteporfin—Discomfort—Etoposide—uterine cancer	0.00194	0.00194	CcSEcCtD
Verteporfin—Hypersensitivity—Dactinomycin—uterine cancer	0.00191	0.00191	CcSEcCtD
Verteporfin—Muscular weakness—Epirubicin—uterine cancer	0.00189	0.00189	CcSEcCtD
Verteporfin—Asthenia—Dactinomycin—uterine cancer	0.00186	0.00186	CcSEcCtD
Verteporfin—Blood creatinine increased—Doxorubicin—uterine cancer	0.00186	0.00186	CcSEcCtD
Verteporfin—Influenza—Epirubicin—uterine cancer	0.00185	0.00185	CcSEcCtD
Verteporfin—Liver function test abnormal—Doxorubicin—uterine cancer	0.00183	0.00183	CcSEcCtD
Verteporfin—Skin disorder—Etoposide—uterine cancer	0.00182	0.00182	CcSEcCtD
Verteporfin—Hyperhidrosis—Etoposide—uterine cancer	0.00182	0.00182	CcSEcCtD
Verteporfin—Muscular weakness—Doxorubicin—uterine cancer	0.00175	0.00175	CcSEcCtD
Verteporfin—Influenza—Doxorubicin—uterine cancer	0.00171	0.00171	CcSEcCtD
Verteporfin—Photosensitivity reaction—Epirubicin—uterine cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Dyspnoea—Etoposide—uterine cancer	0.00167	0.00167	CcSEcCtD
Verteporfin—Pneumonia—Epirubicin—uterine cancer	0.00166	0.00166	CcSEcCtD
Verteporfin—Rash—Dactinomycin—uterine cancer	0.00164	0.00164	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Etoposide—uterine cancer	0.00162	0.00162	CcSEcCtD
Verteporfin—Constipation—Etoposide—uterine cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Pain—Etoposide—uterine cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Conjunctivitis—Epirubicin—uterine cancer	0.0016	0.0016	CcSEcCtD
Verteporfin—Sweating—Epirubicin—uterine cancer	0.00158	0.00158	CcSEcCtD
Verteporfin—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00156	0.00156	CcSEcCtD
Verteporfin—Feeling abnormal—Etoposide—uterine cancer	0.00155	0.00155	CcSEcCtD
Verteporfin—Nausea—Dactinomycin—uterine cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Pneumonia—Doxorubicin—uterine cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Urticaria—Etoposide—uterine cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Haemoglobin—Epirubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Body temperature increased—Etoposide—uterine cancer	0.00148	0.00148	CcSEcCtD
Verteporfin—Conjunctivitis—Doxorubicin—uterine cancer	0.00148	0.00148	CcSEcCtD
Verteporfin—Haemorrhage—Epirubicin—uterine cancer	0.00148	0.00148	CcSEcCtD
Verteporfin—Hypoaesthesia—Epirubicin—uterine cancer	0.00147	0.00147	CcSEcCtD
Verteporfin—Pharyngitis—Epirubicin—uterine cancer	0.00147	0.00147	CcSEcCtD
Verteporfin—Sweating—Doxorubicin—uterine cancer	0.00146	0.00146	CcSEcCtD
Verteporfin—Visual impairment—Epirubicin—uterine cancer	0.00143	0.00143	CcSEcCtD
Verteporfin—Eye disorder—Epirubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Hypersensitivity—Etoposide—uterine cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Haemoglobin—Doxorubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Flushing—Epirubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Cardiac disorder—Epirubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Haemorrhage—Doxorubicin—uterine cancer	0.00137	0.00137	CcSEcCtD
Verteporfin—Hypoaesthesia—Doxorubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Verteporfin—Pharyngitis—Doxorubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Verteporfin—Asthenia—Etoposide—uterine cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Angiopathy—Epirubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Immune system disorder—Epirubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Pruritus—Etoposide—uterine cancer	0.00133	0.00133	CcSEcCtD
Verteporfin—Visual impairment—Doxorubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Verteporfin—Malnutrition—Epirubicin—uterine cancer	0.00129	0.00129	CcSEcCtD
Verteporfin—Eye disorder—Doxorubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Verteporfin—Flushing—Doxorubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Verteporfin—Cardiac disorder—Doxorubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Verteporfin—Back pain—Epirubicin—uterine cancer	0.00125	0.00125	CcSEcCtD
Verteporfin—Angiopathy—Doxorubicin—uterine cancer	0.00124	0.00124	CcSEcCtD
Verteporfin—Dizziness—Etoposide—uterine cancer	0.00124	0.00124	CcSEcCtD
Verteporfin—Immune system disorder—Doxorubicin—uterine cancer	0.00124	0.00124	CcSEcCtD
Verteporfin—Vision blurred—Epirubicin—uterine cancer	0.00122	0.00122	CcSEcCtD
Verteporfin—Ill-defined disorder—Epirubicin—uterine cancer	0.0012	0.0012	CcSEcCtD
Verteporfin—Malnutrition—Doxorubicin—uterine cancer	0.00119	0.00119	CcSEcCtD
Verteporfin—Anaemia—Epirubicin—uterine cancer	0.00119	0.00119	CcSEcCtD
Verteporfin—Rash—Etoposide—uterine cancer	0.00118	0.00118	CcSEcCtD
Verteporfin—Dermatitis—Etoposide—uterine cancer	0.00118	0.00118	CcSEcCtD
Verteporfin—Headache—Etoposide—uterine cancer	0.00118	0.00118	CcSEcCtD
Verteporfin—Malaise—Epirubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Verteporfin—Vertigo—Epirubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Verteporfin—Syncope—Epirubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Verteporfin—Back pain—Doxorubicin—uterine cancer	0.00115	0.00115	CcSEcCtD
Verteporfin—Loss of consciousness—Epirubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Cough—Epirubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Vision blurred—Doxorubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Verteporfin—Nausea—Etoposide—uterine cancer	0.00112	0.00112	CcSEcCtD
Verteporfin—Hypertension—Epirubicin—uterine cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Ill-defined disorder—Doxorubicin—uterine cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Anaemia—Doxorubicin—uterine cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Arthralgia—Epirubicin—uterine cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Chest pain—Epirubicin—uterine cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Discomfort—Epirubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Malaise—Doxorubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Verteporfin—Vertigo—Doxorubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Verteporfin—Syncope—Doxorubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Verteporfin—Oedema—Epirubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Verteporfin—Loss of consciousness—Doxorubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Verteporfin—Cough—Doxorubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Verteporfin—Shock—Epirubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Verteporfin—Nervous system disorder—Epirubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Verteporfin—Hypertension—Doxorubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Verteporfin—Skin disorder—Epirubicin—uterine cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Hyperhidrosis—Epirubicin—uterine cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Arthralgia—Doxorubicin—uterine cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Chest pain—Doxorubicin—uterine cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Verteporfin—Discomfort—Doxorubicin—uterine cancer	0.001	0.001	CcSEcCtD
Verteporfin—Oedema—Doxorubicin—uterine cancer	0.000974	0.000974	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000959	0.000959	CcSEcCtD
Verteporfin—Shock—Doxorubicin—uterine cancer	0.000958	0.000958	CcSEcCtD
Verteporfin—Nervous system disorder—Doxorubicin—uterine cancer	0.000955	0.000955	CcSEcCtD
Verteporfin—Skin disorder—Doxorubicin—uterine cancer	0.000946	0.000946	CcSEcCtD
Verteporfin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000942	0.000942	CcSEcCtD
Verteporfin—Dyspnoea—Epirubicin—uterine cancer	0.000939	0.000939	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000909	0.000909	CcSEcCtD
Verteporfin—Pain—Epirubicin—uterine cancer	0.0009	0.0009	CcSEcCtD
Verteporfin—Constipation—Epirubicin—uterine cancer	0.0009	0.0009	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000887	0.000887	CcSEcCtD
Verteporfin—Dyspnoea—Doxorubicin—uterine cancer	0.000868	0.000868	CcSEcCtD
Verteporfin—Feeling abnormal—Epirubicin—uterine cancer	0.000868	0.000868	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000841	0.000841	CcSEcCtD
Verteporfin—Urticaria—Epirubicin—uterine cancer	0.000836	0.000836	CcSEcCtD
Verteporfin—Constipation—Doxorubicin—uterine cancer	0.000833	0.000833	CcSEcCtD
Verteporfin—Pain—Doxorubicin—uterine cancer	0.000833	0.000833	CcSEcCtD
Verteporfin—Body temperature increased—Epirubicin—uterine cancer	0.000832	0.000832	CcSEcCtD
Verteporfin—Feeling abnormal—Doxorubicin—uterine cancer	0.000803	0.000803	CcSEcCtD
Verteporfin—Hypersensitivity—Epirubicin—uterine cancer	0.000776	0.000776	CcSEcCtD
Verteporfin—Urticaria—Doxorubicin—uterine cancer	0.000774	0.000774	CcSEcCtD
Verteporfin—Body temperature increased—Doxorubicin—uterine cancer	0.00077	0.00077	CcSEcCtD
Verteporfin—Asthenia—Epirubicin—uterine cancer	0.000755	0.000755	CcSEcCtD
Verteporfin—Pruritus—Epirubicin—uterine cancer	0.000745	0.000745	CcSEcCtD
Verteporfin—Hypersensitivity—Doxorubicin—uterine cancer	0.000718	0.000718	CcSEcCtD
Verteporfin—Asthenia—Doxorubicin—uterine cancer	0.000699	0.000699	CcSEcCtD
Verteporfin—Dizziness—Epirubicin—uterine cancer	0.000696	0.000696	CcSEcCtD
Verteporfin—Pruritus—Doxorubicin—uterine cancer	0.000689	0.000689	CcSEcCtD
Verteporfin—Rash—Epirubicin—uterine cancer	0.000664	0.000664	CcSEcCtD
Verteporfin—Dermatitis—Epirubicin—uterine cancer	0.000663	0.000663	CcSEcCtD
Verteporfin—Headache—Epirubicin—uterine cancer	0.00066	0.00066	CcSEcCtD
Verteporfin—Dizziness—Doxorubicin—uterine cancer	0.000644	0.000644	CcSEcCtD
Verteporfin—Nausea—Epirubicin—uterine cancer	0.000625	0.000625	CcSEcCtD
Verteporfin—Rash—Doxorubicin—uterine cancer	0.000614	0.000614	CcSEcCtD
Verteporfin—Dermatitis—Doxorubicin—uterine cancer	0.000614	0.000614	CcSEcCtD
Verteporfin—Headache—Doxorubicin—uterine cancer	0.00061	0.00061	CcSEcCtD
Verteporfin—Nausea—Doxorubicin—uterine cancer	0.000579	0.000579	CcSEcCtD
